| Name | Cvs Pharmacy #17290 |
|---|---|
| Organization Name | Cvs Albany Llc |
| Location | 1598 Flatbush Ave, Brooklyn, New York 11210 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (718) 637-5006 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
But not all the news about ovarian cancer is grim. Incidence is declining. Doctors are learning more about early symptoms and more effective treatments. The September issue of Mayo Clinic Women's HealthSource looks at myths and facts about ovarian cancer.
The NIH's National Institute of Environmental Health Sciences has awarded Tulane University School of Public Health and Tropical Medicine $6.5 million for a five-year study exploring the potential health impacts of the Deepwater Horizon disaster on pregnant women and women of reproductive age living in Louisiana's coastal parishes.
› Verified 6 days ago
| NPI Number | 1609052026 |
| Organization Name | CVS ALBANY LLC |
| Doing Business As | CVS PHARMACY #17290 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1598 Flatbush Ave, Brooklyn, NY 11210 |
| Phone Number | 718-637-5006 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
But not all the news about ovarian cancer is grim. Incidence is declining. Doctors are learning more about early symptoms and more effective treatments. The September issue of Mayo Clinic Women's HealthSource looks at myths and facts about ovarian cancer.
The NIH's National Institute of Environmental Health Sciences has awarded Tulane University School of Public Health and Tropical Medicine $6.5 million for a five-year study exploring the potential health impacts of the Deepwater Horizon disaster on pregnant women and women of reproductive age living in Louisiana's coastal parishes.
› Verified 6 days ago
News Archive
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
But not all the news about ovarian cancer is grim. Incidence is declining. Doctors are learning more about early symptoms and more effective treatments. The September issue of Mayo Clinic Women's HealthSource looks at myths and facts about ovarian cancer.
The NIH's National Institute of Environmental Health Sciences has awarded Tulane University School of Public Health and Tropical Medicine $6.5 million for a five-year study exploring the potential health impacts of the Deepwater Horizon disaster on pregnant women and women of reproductive age living in Louisiana's coastal parishes.
› Verified 6 days ago
1622 Voorhies Ave Pharmacy Inc Type: Community/Retail Pharmacy Location: 1622 Voorhies Ave, Brooklyn, New York 11235 Phone: (347) 462-9778 | |
Clarkson Pharmacy Type: Pharmacy Location: 524 Clarkson Ave, Brooklyn, New York 11203 Phone: (718) 774-1656 | |
21 Ave Pharmacy And Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8511 21st Ave, Brooklyn, New York 11214 Phone: (718) 449-4949 | |
Val U Drugs Type: Medicare Supplier Location: 4623 Church Ave, Brooklyn, New York 11203 Phone: (718) 773-5547 | |
2818 Fulton Street Pharmacy Inc Type: Community/Retail Pharmacy Location: 2818 Fulton St, Brooklyn, New York 11207 Phone: (718) 235-6394 |